Cargando…

A Case of Paroxysmal Cold Hemoglobinuria Possessing Moderate Paroxysmal Nocturnal Hemoglobinuria-Type Erythrocytes

Patient: Female, 82-year-old Final Diagnosis: Paroxysmal cold hemoglobinuria Symptoms: Anemia Medication:— Clinical Procedure: — Specialty: Hematology OBJECTIVE: Challenging differential diagnosis BACKGROUND: Paroxysmal cold hemoglobinuria (PCH) is an autoimmune hemolytic disease caused by the Donat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugimoto, Takeshi, Masui, Eri, Ohata, Shinya, Goto, Hideaki, Tomita, Takako, Hashimoto, Hiromi, Bouike, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630556/
https://www.ncbi.nlm.nih.gov/pubmed/34819489
http://dx.doi.org/10.12659/AJCR.933102
Descripción
Sumario:Patient: Female, 82-year-old Final Diagnosis: Paroxysmal cold hemoglobinuria Symptoms: Anemia Medication:— Clinical Procedure: — Specialty: Hematology OBJECTIVE: Challenging differential diagnosis BACKGROUND: Paroxysmal cold hemoglobinuria (PCH) is an autoimmune hemolytic disease caused by the Donath-Landsteiner (DL) antibody. Paroxysmal nocturnal hemoglobinuria (PNH) is a non-autoimmune hemolytic disease that is caused by a dysfunction in the synthesis of the glycosyl phosphatidylinositol anchor protein, resulting in the deregulation of the complement cascade and hypersensitivity for a hemolytic attack against erythrocytes. The mechanisms of these 2 hemolytic diseases are distinct. If PCH and PNH coexist in a patient, it is difficult to perform a differential diagnosis. We introduce a case of PCH that had DL antibodies and large PNH-type clones. CASE REPORT: An 82-year-old female patient was referred to our hospital because of anemia. Initial workup revealed a negative antiglobulin test and a positive DL test. For the differential diagnosis, we surveyed the population of cells that had PNH-type clones, which revealed erythrocyte PNH clones (19.6%) and granulocyte PNH clones (73.3%). During the patient’s clinical course, mild hemolysis persisted without any attack. The percentage of the PNH-type erythrocytes was not obviously changed, and the DL antibody was detected 8 months after the initial admission. We determined that the persistent mild anemia was caused by concomitant diseases of PCH and PNH, although determining which of the 2 hemolytic systems was primarily responsible for the anemia was difficult. CONCLUSIONS: When considering the differential diagnosis for hemolytic diseases, an adequate combination of laboratory tests for hemolysis is required.